MAC
4th MUNICH AORTIC &
CAROTID CONFERENCE
2014
where doctors meet science
www.mac-conference.com
VENUE
Klinikum rechts der Isar
Munich, Germany
December 5th – 6th, 2014
CHAIRMAN (Technische Universität München, TUM)
n Hans-Henning Eckstein
CO-CHAIRMEN (Technische Universität München, TUM)
n
n
n
n
n
n
Rüdiger Lange
Markus Schwaiger
Holger Poppert
Alma Zernecke
Wolfgang Wall
Michael Gee
AAA-Screening Symposium
in cooperation with
Thursday, December 4th, 2014
TABLE OF CONTENT
n WELCOME ............................................................................................................... 4 – 5
n GENERAL INFORMATION ....................................................................................... 6 – 7
n AAA-SCREENING SYMPOSIUM ............................................................................ 8 – 11
n PROGRAM
Program at a Glance ........................................................................................... 12 – 14
Program Friday, December 5th ........................................................................... 16 – 23
Program Saturday, December 6th ....................................................................... 24 – 27
n WORKSHOPS ............................................ ................................................................. 29
n POSTERSESSIONS AND ORAL PRESENTATIONS ................................................ 30 – 31
n KEYNOTE LECTURES ........................................................................................... 32 – 33
n FACULTY .............................................................................................................. 35 – 38
n SPONSORS .................................................................................................................. 39
www.mac-conference.com
WELCOME
WELCOME
Dear colleagues,
Hans-Henning Eckstein
Klinikum rechts der Isar
der Technischen Universität München
Department for Vascular and Endovascular Surgery
Rüdiger Lange
Deutsches Herzzentrum
der Technischen Universität München
Department for Cardiovascular Surgery
Markus Schwaiger
Klinikum rechts der Isar
der Technischen Universität München
Department for Nuclear Medicine
Holger Poppert
Klinikum rechts der Isar
der Technischen Universität München
Department for Neurology
4
It is thrilling how new diagnostic and therapeutic
methods for vascular diseases are showing up
almost every week. However, to assess this progress
correctly, thorough understanding of the underlying
etiology and the interaction between blood flow
and the atherosclerotic or aneurysmatic arteries is
mandatory. This goal can only be achieved by
mutual exchange between vascular clinicians and
fundamental/translational researchers. Thereby, the
4th Munich Aortic & Carotid Conference (MAC) aims
to connect the frequently diverging worlds of
fundamental science, clinical research and clinical
practice.
We are very happy to invite you to the 4th MAC on
the first December weekend 2014. Again, we will
focus on aortic and carotid issues; a joint meeting
with topics ranging from basic science and engineering to clinical issues and patient care. In detail, the
aortic sessions will include ascending aortic and
aortic arch issues, current indications for TEVAR in
acute aortic dissections and the management of
type II endoleaks after EVAR. Further special sessions
will address the current role of simulation techniques in modeling and understanding of vascular
disease. Since the technical progress in hybrid ORs
is extremely rapid, we will again discuss options on
how to optimize the workflow by using imaging
fusion techniques and endovascular navigation.
The carotid sessions will feature topics, such as
clinical trials, the optimal timing of invasive treatment in carotid-related cerebral ischemia, the
assessment of asymptomatic carotid stenoses, and
carotid plaque vulnerability.
Many attendees of MAC favor to attend all main
carotid and aortic sessions. To overcome the conflict
of parallel sessions, Friday, December 5th will be
reserved for the main aortic sessions and Saturday,
December 6th, for the main carotid sessions respectively. Parallel sessions will only be scheduled for
special issues. Again, we are very proud to present
a world-class faculty of national and international
experts in clinical and translational vascular research.
Our speakers are very experienced presenters and all
of them are keen to exchange their ideas with the
audience. We are fully aware that in-depth discussion
following the oral presentation is sometimes even
more interesting for the audience than the lecture
itself. Therefore, sufficient time is scheduled for
extensive discussions with the audience.
For the first time, scientific abstracts were submitted.
Out of almost 40 submissions we selected seven
abstracts for oral presentation and included them
into the scientific program. Further 27 submitters
were chosen to present their abstracts as posters. The
best presentations will be awarded EUR 500.00!
The 4th MAC 2014 is a platform where clinical
researchers from vascular/cardiovascular surgery,
neurology, cardiology, angiology and anesthesiology
can meet radiologists and imaging specialists, vascular
biologists and basic researchers in a very friendly and
relaxed atmosphere.
Do not miss the opportunity to share the latest
insights into the world of academic vascular research,
represented by our world-class national and international faculty! The 4th MAC will provide you with
late-breaking news and cutting-edge approaches in
vascular medicine and will enable you to be part of
the thrilling progress of improving the diagnosis and
treatment of carotid and aortic diseases.
Alma Zernecke
Universität Würzburg
Institute for Clinical Biochemistry
and Pathobiochemistry
Wolfgang Wall
Technische Universität München
Institute for Computational Mechanics
Michael Gee
Technische Universität München
Mechanics and High Performance
Computing Group
The 4th MAC 2014 is being held under the patronage
of the German Vascular Society (DGG) and the VASCULAR INTERNATIONAL foundation.
We look forward to welcoming you in Munich.
Hans-Henning Eckstein
Rüdiger Lange
Markus Schwaiger
Holger Poppert
Alma Zernecke
Wolfgang Wall
Michael Gee
5
GENERAL INFORMATION
GENERAL INFORMATION
n DATE
Friday and Saturday
December 5th – 6th, 2014
n CERTIFICATION
An application has been made to the Bavarian Medical Association
for CME accreditation of this event.
n VENUE
Klinikum rechts der Isar (MRI) der Technischen Universität München (TUM)
Ismaninger Strasse 22 | 81675 Munich | Germany
n LANGUAGE
The official language of this meeting is English.
There will be no simultaneous translations.
n CONGRESS SECRETARIAT
Kathrin Berkenkamp
Kathrin Ernstberger
Dr. Eva Knipfer
Dr. Heidi Söllner
n REGISTRATION FEE
Department for Vascular and Endovascular Surgery
Klinikum rechts der Isar der Technischen Universität München
Ismaninger Strasse 22
81675 Munich | Germany
Phone: +49 (0)89 41 40 21 67
Fax: +49 (0)89 41 40 48 61
E-Mail: [email protected]
n CONGRESS ORGANISATION
Full Registration
Day Registration
Dec. 5th
Dec. 6th
Physicians
EUR 300.00
EUR 200.00
EUR 200.00
Physicians in training
EUR 200.00
EUR 150.00
EUR 150.00
Fellows, Nurses and MTs
EUR 100.00
EUR 50.00
EUR 50.00
Students (written confirmation required)
free of charge
Food and Beverages are included in the registration fee.
For registration please use the website www.mac-conference.com or the attached
registration form.
n GET-TOGETHER
Friday, December 5th, 2014 | 19:30
EUR 50.00 per person
KelCon GmbH
Franziska Klug
Liebigstrasse 16 | 63500 Seligenstadt | Germany
Phone: +49 (0)6182 94 666 16
Fax: +49 (0)6182 94 666 44
E-Mail: [email protected]
www.kelcon.de
n TRAVEL MANAGEMENT
Our travel management is looking forward to assisting you
with the organisation and booking of your journey.
Any program changes will be published on our website
on a regular basis. For detailed information visit
www.mac-conference.com
Phone: +49 (0)6182 94 666 22
E-Mail: [email protected]
6
7
in Kooperation mit
in cooperation with
in Kooperation mit
in cooperation with
Hörsaal C
Münchner AAA-Screening Symposium
th
In Kooperation mit der 4 Munich Aortic & Carotid Conference (MAC) und der
Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG)
In cooperation with the 4th Munich Aortic & Carotid Conference (MAC) and the
German Vascular Society (DGG)
10:30-11:00
Einschreiben / Registration
11:00-11:05
Begrüßung / Welcome H.-H. Eckstein, Munich, Germany
11:05-12:35
Ultraschall-Screening des abdominalen Aortenaneurysmas (AAA) –
Studien, Evidenz, internationale Programme
Ultrasound screening of abdominal aortic aneurysms (AAA) –
trials, evidence, international implementation
Vorsitz / Chairs:
Donnerstag, 4. Dezember 2014, 11:00–17:00 Uhr
Thursday, December 4th, 2014, 11:00 am until 5:00 pm
S. Teupen, Berlin, Germany; G. Torsello, Münster, Germany
B-Bild-Sonographie der abdominalen Aorta:
Technik, Qualifikation und Dokumentation – Standards der Deutschen
Gesellschaft für Ultraschall in der Medizin (DEGUM)
B-Mode-Sonography of the abdominal aorta – standards of the German
Society for Ultrasound in Medicine
Deutsch / Englisch mit Simultanübersetzung · Eintritt frei
German / English with simultaneous translation · Free entrance
Organisation und Leitung/Chairs:
W. Schäberle, Göppingen, Germany
• Hans-Henning Eckstein, Chief Editor GEFAESSCHIRURGIE
Ehemaliger Präsident der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG)
Past-President of the German Vascular Society (DGG)
Behandlung des AAA in Deutschland – AAA-Register der Deutschen Gesellschaft
für Gefäßchirurgie und Daten des Statistischen Bundesamtes 2000 bis 2013
Treatment of AAA in Germany – the AAA Registry of the German Vascular
Society and data of the Federal Bureau of Statistics
• Sebastian Debus
Präsident der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG)
President of the German Vascular Society (DGG)
M. Trenner, London / Munich, United Kingdom / Germany
Ultraschall-Screening – aktuelle Studienlage
AAA screening trials
• Giovanni Torsello
Vizepräsident der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG)
Vice President of the German Vascular Society (DGG)
H.-H. Eckstein, Munich, Germany
Risikofaktoren für die Entstehung eines AAA oder:
welche Population soll gescreent werden?
Risk factors for AAA or: who should be screened?
• Susanne Teupen
Stabsstelle Patientenbeteiligung beim Gemeinsamen Bundesausschuss (G-BA)
Subcommittee on patient involvement, Federal Joint Committee (G-BA)
I. Flessenkämper, Berlin, Germany
Ethische Aspekte von Screening Untersuchungen
Ethical aspects of screening
I. Mühlhauser, Hamburg, Germany
Zusammenfassung / Summary
www.mac-conference.com
8
S. Teupen, Berlin, Germany; G. Torsello, Münster, Germany
12:35-13:20
M I T TA G S PA U S E / L U N C H
9
in Kooperation mit
in cooperation with
13:20-14:40
in Kooperation mit
in cooperation with
Sicht der Kassenärztlichen Bundesvereinigung (KBV)
AAA screening programs in Europe and overseas
View of the National Association of Statutory Health Insurance Physicians
S. Steiner, Berlin, Germany (tbc)
Vorsitz / Chairs:
H.-H. Eckstein, Munich, Germany; I. Flessenkämper, Berlin, Germany
Sicht der deutschen Krankenhausgesellschaft
View of the German Hospital Federation
AAA screening in the United States
N. Schlottmann, Berlin, Germany (tbc)
F. Mussa, New York, USA
Stand des Projektes AAA Screening beim G-BA
The NHS AAA screening program in the United Kingdom
Current status of the project „AAA screening“ at the
Federal Joint Commitee (G-BA)
J. Earnshaw, Gloucestershire, United Kingdom
S. Teupen, Berlin, Germany
AAA screening in the context of a changing epidemiology, which intervals are
reasonable and should subaneurysmatic aortas be rescreened? –
the Swedish AAA screening program
Zusammenfassung / Summary
S. Debus, Hamburg; S. Teupen, Berlin, Germany
M. Björck, Uppsala, Sweden
AAA screening trials in Denmark
H. Sillesen, Copenhagen, Denmark
16:55-17:00
VERABSCHIEDUNG/FAREWELL
H.-H. Eckstein, Munich, Germany
AAA screening in Poland
A. Jawien, Bydgoszcz, Poland, President ESVS
The prevalence of AAA and PAD amongst 4 million screened US adults and the
importance of smoking as a risk factor
R. Bulbulia, Oxford, United Kingdom
14:40-15:10
K A F F E E PA U S E / C O F F E E B R E A K
15:10-16:55
Umsetzung eines AAA-Screening-Programm in Deutschland
How to implement a national AAA screening program in Germany
Vorsitz / Chairs:
S. Debus, Hamburg; U. Hoffmann, Munich; S. Teupen, Berlin, Germany
Sicht der Deutschen Gesellschaft für Angiologie (DGA)
View of the German Society of Angiology
U. Hoffmann, Munich, Germany
Sicht der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG)
View of the German Vascular Society
S. Debus, Hamburg, Germany
10
REFERENTEN / FACULTY
n Martin Björck, Uppsala, Sweden
n Richard Bulbulia, Oxford, United Kingdom
n Jonothan Earnshaw, Gloucestershire, United Kingdom
n Ingo Flessenkämper, Berlin, Germany
n Ulrich Hoffmann, Munich, Germany
n Arkadiusz Jawien, Bydgoszcz, Poland
n Ingrid Mühlhauser, Hamburg, Germany
n Firas Mussa, New York, USA
n Wilhelm Schäberle, Göppingen, Germany
n Nicole Schlottmann, Berlin, Germany (tbc)
n Henrik Sillesen, Copenhagen, Denmark
n Sybille Steiner, Berlin, Germany (tbc)
n Matthias Trenner, London / Munich, United Kingdom / Germany
11
PROGRAM AT A GLANCE
Friday, December 5
LECTURE HALL B
Aortic issues
09:00–
10:40
10:40–
11:05
Keynote lecture
Carotid issues
11:05–
12:35
MAC 1
Endovascular solutions for the ascending
aorta and arch aneurysms
LECTURE HALL C
09:00– MCC 1
10:40 Advances in carotid plaque biology
MAC 2
11:05–
12:30
MCC 2
Carotid ultrasound beyond the degree of
stenosis
12:55–
14:00
Keynote lecture
14:00–
15:15
LUNCH BREAK IN THE EXHIBITION AREA
MAC 3
Aortic emergencies II: ruptured AAA
16:00–
16:30
11:00–
12:35
MAC 6
Aortic emergencies III: the infected aorta
LECTURE HALL B
09:00–
10:30
MCC 4
The future of Carotid Artery Stenting
(CAS)
COFFEE BREAK IN THE EXHIBITION AREA
MAC 7
Perioperative imaging, fusion and navigation
11:00–
12:35
MCC 5
Asymptomatic carotid disease
LECTURE HALL C
14:00–
15:15
Keynote lecture
F. J. Veith, New York, USA
PAVILLON
MCC 3
Functional imaging of atherosclerotic lesions
LECTURE HALL B
15:20–
16:00
09:00–
10:30
12:40–
13:00
H. J. Safi, Houston, USA
LECTURE HALL B
LECTURE HALL C
LECTURE HALL B
LECTURE HALL B
12:35–
12:55
Saturday, December 6th
10:30–
11:00
COFFEE BREAK IN THE EXHIBITION AREA
Aortic emergencies I: acute Type B Aortic
Dissection (TBAD)
PROGRAM AT A GLANCE
th
13:00–
14:00
Poster Session II (No. 15-27)
13:00–
14:00
LUNCH BREAK IN THE EXHIBITION AREA
LECTURE HALL B
Keynote lectures
MCC 6
V. Ntziachristos, Munich, Germany
P. Lawrence, Los Angeles, USA
14:00–
15:45
Carotid trials and the impact of TIME in symptomatic patients
COFFEE BREAK IN THE EXHIBITION AREA
15:45
FAREWELL
PAVILLON
16:00–
17:30
Poster Session I (No. 1-14)
LECTURE HALL B
16:30–
18:15
19:30
12
MAC 4
Endoleaks and other follow-up issues after
EVAR
LECTURE HALL C
16:30–
18:15
MAC 5
Computational modeling of cardiovascular
diseases and their treatment
G E T- T O G E T H E R
13
PROGRAM AT A GLANCE
Symposia and Workshops
Friday, December 5th
Miscellaneous
LECTURE HALL B
LECTURE HALL C
Lunch Symposium I COOK
13:00–
13:50
Clinical practice in EVAR and experiences
with Zenith Alpha™ Thoracic and Zenith
t-Branch
13:00–
13:50
Lunch Symposium II LOMBARD
The Aorfix™ Endovascular Stent Graft:
a solution for the everyday to the extreme
CONFERENCE ROOM I
14:00–
16:00
Workshop I TRIVASCULAR
Saturday, December 6th
OPERATION ROOM III
09:00–
10:00
Workshop II VASCUTEK HANDS-ON TRAINING Course I
10:30–
11:30
Workshop II VASCUTEK HANDS-ON TRAINING Course II
CONFERENCE ROOM I
11:15–
12:15
Workshop III ENDOLOGIX
OPERATION ROOM III
12:00–
13:00
Workshop II VASCUTEK HANDS-ON TRAINING Course III
LECTURE HALL B
13:10–
14:00
14
Lunch Symposium III CORDIS
First practical experiences with the 14 F ultra
low profile INCRAFT AAA Stent Graft System
LECTURE HALL C
Lunch Symposium IV GE
13:10–
14:00
Hybrid-OR Workflow symposium:
Interventional procedures using 3D image
fusion and implications on dose
PROGRAM
PROGRAM
Friday, December 5
Friday, December 5th
LECTURE HALL B
Carotid issues
Aortic issues
09:00
Welcome
R. Lange, Munich, Germany
th
LECTURE HALL C
09:00
LECTURE HALL B
LECTURE HALL C
The ascending aorta:
Is the endovascular approach realistic?
Welcome
A. Zernecke, Würzburg, Germany
T. Kölbel, Hamburg, Germany
09:00– MAC 1
10:40 Endovascular solutions for the
ascending aorta and arch
aneurysms
Chair: M. Jacobs, Maastricht / Aachen,
The Netherlands / Germany;
R. Lange, Munich, Germany
Incidence and treatment options for
retrograde type A dissections after
TEVAR
09:00– MCC 1
10:40 Advances in carotid plaque
J. Pelisek, Munich, Germany
Redo procedures for arch diseases –
endo or open?
biology
Chair: J. Pelisek, Munich, Germany;
A. Zernecke, Würzburg, Germany
MicroRNAs in atherosclerosis
The impact of patient age on
carotid atherosclerosis – results from
the Munich carotid biobank
M. Jacobs, Maastricht / Aachen,
The Netherlands / Germany
10:40–
11:05
COFFEE BREAK IN THE EXHIBITION AREA
C. Weber, Munich, Germany
M. Czerny, Zurich, Switzerland
Ascending aortic TEVAR – the first
FDA–approved study
Role of vascular stem cells in
atherosclerosis
A. Khoynezhad, Los Angeles, USA
Q. Xu, London, UK
Planning of branched grafts and
in-situ-fenestration for endovascular
aortic arch repair
miR-92a in atherosclerosis
X. Loyer, Paris, France
T. A. Resch, Malmö, Sweden
Aortic arch repair with branched
endografts
Macrophage polarization and epigenetic regulation in atherosclerosis
S. Haulon, Lille, France
M. de Winther, Amsterdam, The Netherlands
TEVAR and chimneys for arch
pathologies – results from the
PERICLES registry
Abstract I:
Neutrophil gelatinase-associated
lipocalin (NGAL): clinical relevance in
carotid atherosclerosis
K. Donas, Münster, Germany
W.-H. Eilenberg, Vienna, Austria
Endografting and adjuncts for
aortic arch aneurysms
P. Kasprzak, Regensburg, Germany
Long-term results after TEVAR and
supraaortic debranching procedures
Activation of the proapoptotic
unfolded protein response in plaques
of the human carotid artery
B. Dorweiler, Mainz, Germany
S. Ockert, Luzern, Switzerland;
C. Reeps, Munich, Germany
16
17
PROGRAM
PROGRAM
Friday, December 5
Friday, December 5th
LECTURE HALL B
Carotid issues
Aortic issues
11:05– MAC 2
12:35 Aortic emergencies I: acute
Keynote lecture
LECTURE HALL C
Type B Aortic Dissection (TBAD)
MCC 2
Carotid ultrasound beyond the
degree of stenosis
Chair: E. S. Debus, Hamburg, Germany;
F. L. Moll, Utrecht, The Netherlands
Chair: E. Bartels, Munich, Germany;
H. Sillesen, Copenhagen, Denmark
Emergency treatment of TBAD in
patients with connective tissue disease
Juxtaluminal black plaque area
represents vulnerable carotid plaques
R. Gibbs, London, UK
S. Kakkos, Patras, Greece
Treatment options for malperfusion
in TBAD
Contrast-enhanced ultrasound to
assess neovascularization of the
carotid bifurcation
G.Torsello, Münster, Germany
Indications and outcomes for hybrid
procedures in acute TBAD
Miscellaneous
th
E. S. Debus, Hamburg, Germany
Symptoms, treatment options and
outcomes of TBAD – a single center series
11:05–
12:30
D. Staub, Basel, Switzerland
Contrast-enhanced ultrasound of the
carotid bifurcation – our experiences
at the Klinikum rechts der Isar
K. Stock, Munich, Germany
B. Reutersberg, Munich, Germany
Prediction of growth of uncomplicated
TBAD
IMT measurement: useful or useless?
What can we learn from actual studies?
F. L. Moll, Utrecht, The Netherlands
D. Sander, Tutzing, Germany
Predictors of clinical success after
TEVAR for TBAD
Asymptomatic carotid stenosis in the
High Risk Plaque (HRP) study
I. Loftus, London, UK
H. Sillesen, Copenhagen, Denmark
TEVAR is beneficial in selected patients
with uncomplicated TBAD – but the
final answer can only be given by a RCT
The role of cerebral vasoreactivity
and emboli signal detection in the
prediction of carotid-related strokes
F. Mussa, New York, USA
E. B. Ringelstein, Münster, Germany
LECTURE HALL B
12:35–
12:55
Keynote lecture
Thoracoabdominal aortic aneurysms
H. J. Safi, Houston, USA
Introduction: M. Jacobs, Maastricht / Aachen, The Netherlands / Germany
12:55–
14:00
LUNCH BREAK IN THE EXHIBITION AREA
13:00–
13:50
Lunch Symposium I
COOK
13:00–
13:50
Lunch Symposium II
LOMBARD
Clinical practice in EVAR and
experiences with Zenith Alpha™
Thoracic and Zenith t-Branch
The Aorfix™ Endovascular
Stent Graft: a solution for
the everyday to the extreme
Chair: P. Kasprzak, Regensburg, Germany
Chair: J. Tessarek, Lingen, Germany
Why is a durable repair important?
Single-center case series:
how Aorfix can address angulated necks
and tortuous iliacs
P. Kasprzak, Regensburg, Germany
Experiences with Zenith Alpha™
Thoracic Endovascular Graft
R. Kellersmann, Würzburg, Germany
G. Torsello, Münster, Germany
7-year clinical experience with Aorfix
Zenith t-Branch: an off-the-shelf
solution for endovascular treatment of
thoracoabdominal aneurysms
J. Hardman, Bath / Bristol, UK
B. Modarai, London, UK
V. Makaloski, Berne, Switzerland
Discussion
Procedural overview and tips & tricks
Pan-European experience with Aorfix
N. Mosquera, Ourense, Spain
DEBATE:
TEVAR should be the standard of care
for uncomplicated acute TBAD
- for the motion
J. Brunkwall, Cologne, Germany
- against the motion
A. Khoynezhad, Los Angeles, USA
18
15
19
PROGRAM
PROGRAM
Friday, December 5
Friday, December 5th
LECTURE HALL B
MAC 3
Aortic emergencies II:
ruptured AAA
14:00–
15:15
LECTURE HALL B
MCC 3
Functional imaging of
atherosclerotic lesions
15:20–
16:00
Keynote lectures
Sensing and imaging needs in modern vascular medicine
Chair: P. Lawrence, Los Angeles, USA;
M. Malina, Malmö, Sweden
Chair: J. Rudd, Cambridge, UK;
M. Schwaiger, Munich, Germany
V. Ntziachristos, Munich, Germany Introduction: M. Schwaiger, Munich, Germany
Abstract II:
Forecasting AAA rupture – seasonal
and atmospheric associations
3D Black-Blood Imaging of the
vessel wall and beyond
P. Lawrence, Los Angeles, USA
A. Choong,
London / Queensland, UK / Australia
DEBATE:
With appropriate adjuncts almost
100% of rAAAs can be treated by
EVAR
The role of PET imaging in the
evaluation of carotid plaques
F. Hyafil, Munich, Germany
- pro
F. J. Veith, New York, USA
F. Mussa, New York, USA
- con
Improving care of patients with
ruptured AAA:
lessons from USA and UK
R. Hinchliffe, London, UK
Theory and practise of vascular surgical training in the 21st century
16:00–
16:30
T. Saam, Munich, Germany
PET-MR for asymptomatic carotid
stenosis: the final answer on who
needs carotid intervention
J. Schmidli, Berne, Switzerland
Miscellaneous
LECTURE HALL C
The role of FDG-PET for the
evaluation of novel therapies
aimed at plaque stabilization
J. Rudd, Cambridge, UK
Introduction: H.-H. Eckstein, Munich, Germany
COFFEE BREAK IN THE EXHIBITION AREA
PAVILLON
P A R A L L E L W O R K S H O P S page 29
Keynote lecture
Carotid issues
Aortic issues
14:00–
15:15
th
16:00–
17:30
Poster Session I (No. 1-14)
Chair: A. Assadian, Vienna, Austria; T. Mastracci, Cleveland / London, USA / UK
EndoAnchors in urgent AAA –
does it work?
J. P. de Vries, Nieuwegein, The Netherlands
Neck length predicts outcome of ruptured AAA independently of repair
F. Dick, Berne, Switzerland
An update on the abdominal compartment syndrome. What is new?
M. Björck, Uppsala, Sweden
20
21
PROGRAM
PROGRAM
Friday, December 5
Friday, December 5th
LECTURE HALL B
Aortic issues
16:30–
18:15
MAC 4
Endoleaks and other
follow-up issues after EVAR
Chair: T. Köppel, Munich, Germany;
C. Liapis, Athens, Greece
th
LECTURE HALL C
16:30–
18:15
LECTURE HALL B
Stratified surveillance and long-term
mortality after EVAR
MAC 5
Computational modeling of
cardiovascular diseases and their
treatment
R. Hinchliffe, London, UK
DEBATE:
Despite all this, EVAR is safe and durable, the debate about EVAR versus OR
should be finished
Chair: M. Gee, Garching, Germany;
D. Liepsch, Munich, Germany;
W. Wall, Munich, Germany
De novo periaortic inflammatory
reaction after EVAR
Prediction of EVAR outcome by means
of computational models
- for the motion
A. Stella, Bologna, Italy
F. Auricchio, Pavia, Italy
- against the motion
Iliac endograft thrombosis and
reinterventions after EVAR
Ultrasound based characterization of
aortic and carotid vessel wall properties
M. Jacobs, Maastricht / Aachen, The Netherlands /
Germany
A. Mansilha, Porto, Portugal
F. van de Vosse, Eindhoven, The Netherlands
Failure modes of infrarenal stentgrafts
in AAA – Go FEVAR!
New MR imaging methodology to
measure the elasticity of the aortic wall
in vivo
M. Malina, Malmö, Sweden
19:30
T. Mastracci, Cleveland / London, USA / UK
LECTURE HALL C
G E T- T O G E T H E R
R. Clough, London, UK
Detection of type II endoleaks by CTA or
MRA and what is a durable (>5 years)
treatment?
F. J. Moll, Utrecht, The Netherlands
Abstract III:
Dissection properties and mass fractions
of the AAA wall and the intraluminal
thrombus
T. Cohnert, Graz, Austria
Mid-term results of 107 reinterventions
after complicated EVAR
J. P. de Vries, Nieuwegein, The Netherlands
Abstract IV:
Determining the biomechanical
properties of infrarenal aortic aneurysms
W. Derwich, Frankfurt, Germany
Coil and glue embolisation of type II
endoleaks - a critical review
I. Loftus, London, UK
Coping with parametric uncertainty in
the computational assessment of AAA
rupture risk
J. Biehler, Garching, Germany
22
Influence of normal post procedural CT on
requirement for secondary intervention
after EVAR in an unselected population
The change of geometrical and
biomechanical properties during AAA
expansion
J. Scott, Leeds, UK
T. C. Gasser, Stockholm, Sweden
23
PROGRAM
LECTURE HALL C
MAC 6
Aortic emergencies III:
the infected aorta
LECTURE HALL B
09:00–
10:30
MCC 4
The future of Carotid Artery
Stenting (CAS)
11:00–
12:35
MAC 7
Perioperative imaging,
fusion and navigation
MCC 5
Asymptomatic carotid
disease
Chair: S. Haulon, Lille, France;
A. Zimmermann, Munich, Germany
Chair: B. Hemmer, Munich, Germany;
R. Naylor, Leicester, UK
New less invasive paradigm for
treating aortic infection
Which patient subgroups do
benefit from CAS?
M. Malina, Malmö, Sweden
A. Stella, Bologna, Italy
Patient and surgeon radiation
protection during endovascular
procedures
Aortic graft infection – current
diagnosis and management,
including in-line autogenous
reconstruction
What kind of training and volume is
necessary to perform CAS safely?
Abstract VII:
The prevalence of carotid stenosis
and atrial fibrillation amongst
4 million screened US adults and
the importance of smoking as a risk
factor
A. Dörfler, Erlangen, Germany
Will the newest generation carotid
stents resuscitate CAS?
M. Bosiers, Dendermonde, Belgium
M. Björck, Uppsala, Sweden
Self-made pericardial tube grafts
for infected aortic protheses
C. Reeps, Munich, Germany
Our experience in acute CAS with
our strategy of selection and
procedure
G. Coppi, Modena, Italy
Are there still indications for silver
and antibiotic-coated grafts?
A. Assadian, Vienna, Austria
Abstract V:
Deep veins for aortic reconstruction
Despite current level 1 evidence,
the outlook for an upsurge in CAS
is bright
F. J. Veith, New York, USA
C. Domenig, Vienna, Austria
Abstract VI:
Two-step hybrid technique for the
treatment of secondary aortoenteric
fistula using endovascular aortic
occlusion followed by surgical
explant and intestinal repair
G. Coppi, Modena, Italy
C. Liapis, Athens, Greece
Fusion technology for
intraoperative dose reduction
S. Haulon, Lille, France
Sealing of endografts and the fate
of the supra- and infrarenal angulation after EVAR – new software
solution
J. P. de Vries, Nieuwegein, The Netherlands
Vessel Navigator: a new fusion
technique to reduce contrast media
and radiation
J. Brunkwall, Cologne, Germany
Fusion techniques to facilitate navigation in fenestrated and branched
endografting
G. Panuccio, Münster, Germany
Abstract IX:
VIII:
Abstract
An experimental setAnfor
experimental
set-up for navigaup
navigated-contrast-agent
ted-radiation
contrast-agent
and
radiation
and
sparing
endovascular
sparing
endovascular aortic repair
aortic
repair
M.Kleemann,
Kleemann,Lübeck,
Lübeck,Germany
Germany
M.
Preoperative imaging of spinal
perfusion in thoracoabdominal
aneurysms
A. Huber, Munich, Germany
24
11:00–
12:35
Chair: L. Bonati, Basel, Switzerland;
F. J. Veith, New York, USA
EVAR for mycotic aortic aneurysms,
a multinational experience of
132 cases
10:30–
11:00
LECTURE HALL B
Chair: M. Björck, Uppsala, Sweden;
M. Steinbauer, Regensburg, Germany
P. Lawrence, Los Angeles, USA
Miscellaneous
LECTURE HALL C
P A R A L L E L W O R K S H O P S page 29
Carotid issues
Aortic issues
09:00–
10:30
Saturday, December 6th
COFFEE BREAK IN THE EXHIBITION AREA
R. Bulbulia, Oxford, UK
Predictors and clinical significance
of progression or regression of
asymptomatic carotid stenosis
S. Kakkos, Patras, Greece
Plaque structure is relevant for risk
stratification in asymptomatic
carotid disease. Its clinical use is
mandatory
J. Fernandes e Fernandes, Lisbon, Portugal
Biomarkers – might they help to
identify carotid patients at risk?
C. Liapis, Athens, Greece
P A R A L L E L W O R K S H O P S page 29
Saturday, December 6
PROGRAM
th
DEBATE:
Do we really need a new definition
of “stroke and TIA”
(as proposed by the AHA)?
Yes, because modern neuroimaging
can clearly identify cerebral
infarction
P. Ringleb, Heidelberg, Germany
No, stroke and TIA need to remain
clinical diagnoses: to change would
be bonkers!
A. Abbott, Melbourne, Australia
25
PROGRAM
Saturday, December 6
PROGRAM
Saturday, December 6th
th
LECTURE HALL B
Keynote lecture
Aortic issues
Why the ongoing initiative to separate physicians from industry is bad for patient
care and society
F. J. Veith, New York, USA Introduction: H.-H. Eckstein, Munich, Germany
Carotid issues
PAVILLON
13:00– Poster Session II (No. 15-27)
14:00
Keynote lecture
14:00–
15:45
MCC 6
Carotid trials and the impact of TIME in symptomatic patients
Chair: H.-H. Eckstein, Munich, Germany; H. Poppert, Munich, Germany
Current guidelines on carotid disease are obsolete and have to be improved!
A. Abbott, Melbourne, Australia
Status and perspectives of ECST-2 and CREST-2
L. Bonati, Basel, Switzerland
Chair: J. Schmidli, Berne, Switzerland; J. Scott, Leeds, UK
Update of ACST 2
13:00–
14:00
13:10–
14:00
A. Halliday, Oxford, UK
LUNCH BREAK IN THE EXHIBITION AREA
LECTURE HALL B
Miscellaneous
PA R A L L E L
W O R K S H O P S page 29
12:40–
13:00
LECTURE HALL B
Lunch Symposium III
CORDIS
First practical experiences with
the 14F ultra low profile INCRAFT
AAA Stent Graft System
SPACE-2, why was the protocol modification not successful?
LECTURE HALL C
13:10–
14:00
P. Ringleb, Heidelberg, Germany
Lunch Symposium IV
GE
Chair: M. Sadeghi, Erding, Germany (tbc)
Hybrid-OR Workflow symposium:
Interventional procedures using
3D image fusion and implications
on dose
First practical experiences from the
St. Franziskus Hospital, Münster
Fusion imaging technique:
why, how, where?
B. Gehringhoff, Münster, Germany
S. Haulon, Lille, France
First practical experiences from the
Klinikum rechts der Isar
How fusion imaging has found its place
during abdominal CTO?
C. Reeps, Munich, Germany
K. Overbeck, Sunderland, UK
Time heals all wounds….?
Natural history and the risk of early interventions in symptomatic carotid disease
R. Naylor, Leicester, UK
Long-term outcome after CAS versus CEA for symptomatic carotid stenosis:
new data from ICSS and the Carotid Stenosis Trialists’ Collaboration
L. Bonati, Basel, Switzerland
Is a short time interval between the neurological index event a risk factor for CEA or CAS? –
a nationwide analysis of CEA and CAS for symptomatic patients in Germany
P. Tsantilas, Munich, Germany; A. Kühnl, Munich, Germany
15:45
FAREWELL
H.-H. Eckstein, Munich, Germany
Benefits of advanced imaging techniques
during peripheral procedures
M. Bosiers, Dendermonde, Belgium
26
27
WORKSHOPS
CONFERENCE ROOM I
14:00–
16:00
(Friday, December 5th)
Workshop I TRIVASCULAR
Ovation Prime – the science of seal
Causes and risks of aortic neck dilatation:
the evolution of a novel technology to preserve the aortic neck
R. Whirley, Santa Rosa, USA
TRAINING:
Ovation Prime Hands-On, Indication and Case-planning
OPERATION ROOM III
(Saturday, December 6th)
Workshop II VASCUTEK
Fenestrated anacondaTM
09:00–
10:00
HANDS-ON TRAINING Course I
10:30–
11:30
HANDS-ON TRAINING Course II
12:00–
13:00
HANDS-ON TRAINING Course III
CONFERENCE ROOM I
11:15–
12:15
(Saturday, December 6th)
Workshop III ENDOLOGIX
Chair: A. Oberhuber, Düsseldorf, Germany
Nellix, what else? Single-center experience with 40 Nellix implantations
A. Oberhuber, Düsseldorf, Germany
HANDS-ON TRAINING
www.mac-conference.com
29
Carotid issues
Aortic issues
POSTERSESSIONS AND
1.
Protective role of statin therapy in thoracoabdominal aortic surgery
J. Grommes; A. Greiner,
Aachen, Germany
23.
The ration of Apolipoptotein A-II/B predicts overall survival
after carotid surgery
N. Duschek, Vienna, Austria
2.
A comparison between contrast-enhanced ultrasound and CTA in
detecting and classifying endoleaks after EVAR
G. Meimarakis, Munich, Germany
24.
Low homocysteine concentrations predict a higher likelihood of TIA
than stroke in patients with a symptomatic carotid stenosis
N. Duschek, Vienna, Austria
3.
The influence of the Ovation’s Stent Graft fixation mode on the direct
postoperative suprerenal neck angulation change; comparison to the
Nitinol self-expanding stent mechanism
E. Georgakarakos,
Alexandroupolis, Greece
4.
Establishment of a 3D-Model of the murine aortic arch
A. Glinzer, Munich, Germany
5.
Combined surgery on the aorta, carotid artery and thyroid gland
P. Stepinski, Nowa Sol, Poland
6.
Emergent open interventions after EVAR: strategies and outcome
C. Domenig, Vienna, Austria
7.
TEVAR for blunt aortic injury
V. Makaloski, Berne, Switzerland
8.
TEVAR implantation as elephant trunk during conventional arch
replacement
N. Tabuchi, Yokohama, Japan
Long-term patency of renal and visceral vessels after open TAAA repair
B. Dorweiler, Mainz, Germany
First results of ChEVAS (Chimney EndoVascular Aneurysm Sealing)
S. Zerwes, Augsburg, Germany
11.
Renal ischemic lesion in fEVAR
R. Pini, Modena, Italy
12.
Fenestrated/branched endograft after previous aortic surgery
E. Gallitto, Bologna, Italy
Initial single-center experience with the Ovation stent-graft system
E. Georgakarakos,
Alexandroupolis, Greece
9.
10.
13.
25. Aneurysm of the brachiocephalic trunk and a tracheal fistula – case report
D. Metz, Halle a. d. Saale, Germany
26.
The utility of Piton catheter in TEVAR
A. Lauricella, Modena, Italy
27.
Perioperative visual field changes after carotid endarterectomy
P. Konstantiniuk, Graz, Austria
The best two posters will be awarded with EUR 500.00 each!
Oral Presentations | Friday, December 5th
Abstract I
Neutrophil gelatinase-associated lipocalin (NGAL): clinical relevance in carotid atherosclerosis
in MCC 1 09:00–10:40
W.-H. Eilenberg, Vienna, Austria
Abstract II
Forecasting AAA rupture – seasonal and atmospheric associations
in MAC 3 14:00–15:15
A. Choong, London / Queensland, UK / Australia
Abstract III
Dissection properties and mass fractions of the AAA wall and the intraluminal thrombus
in MAC 5 16:30–18:15
T. Cohnert, Graz, Austria
Abstract IV
Determining the biomechanical properties of infrarenal aortic aneurysms
in MAC 5 16:30–18:15
W. Derwich, Frankfurt, Germany
14.
Identification of material parameters of soft tissue: toward inverse A
S. Kehl, Garching, Germany
15.
Blunt traumatic thoracic aortic injury: time for a standardised
grading system?
A. Choong,
London / Queensland, UK / Australia
Endovascular aneurysm repair via carotid artery access:
a viable alternative?
A. Choong,
London / Queensland, UK / Australia
Abstract V
Deep veins for aortic reconstruction
16.
in MAC 6 09:00–10:30
C. Domenig, Vienna, Austria
First experience of endovascular sealing (Nellix) in a ruptured
abdominal aortic aneurysm: a case report of an elderly patient
Abstract VI
17.
G. Saitta, Modena, Italy
in MAC 6 09:00–10:30
Two-step hybrid technique for the treatment of secondary aortoenteric fistula using
endovascular aortic occlusion followed by surgical explant and intestinal repair
18.
Paraplegia prevention in TEVAR: the use of Remifentanyl
S. Gennai, Modena, Italy
19.
NELLIX 2.0: single-center experience with 40 NELLIX implantations
H. Schelzig, Düsseldorf, Germany
First experiences with self-made pericardial tube grafts for infected
20.
aortic grafts
30
ORAL PRESENTATIONS
Oral Presentations | Saturday, December 6th
G. Coppi, Modena, Italy
B. Lutz, Munich Germany
Abstracts VII
in MCC 5 11:00–12:35
R. Bulbulia, Oxford, UK
Abstract VIII
in MAC 7 11:00–12:35
21.
The impact of time on outcome of CEA in symptomatic patients
P. Tsantilas, Munich, Germany
22.
Carotid surgery risk stratification
J. Basic, Vienna, Austria
The prevalence of carotid stenosis and atrial fibrillation amongst 4 million screened US
adults and the importance of smoking as a risk factor
An experimental set-up for navigated- contrast-agent and radiation sparing endovascular
aortic repair
M. Kleemann, Lübeck, Germany
The best oral Presentation will be awarded with EUR 500.00!
31
KEYNOTE LECTURES
n Thoracoabdominal aortic aneurysms
th
Prof. Hazim J. Safi, MD
Houston | USA
Munich | Germany
32
n Theory and practise of vascular surgical training in the 21st century
December 5 , 2014 | 12:35–12:55
December 5th, 2014 | 15:40–16:00
Hazim J. Safi is one of the leading specialists worldwide for open thoracoabdominal
aortic surgery. He is Professor and Chairman of the Department of Cardiothoracic
and Vascular Surgery at the University of Texas Medical School in Houston and
also author and co-author of more than 30 book chapters and over 200 scientific
publications in medical journals. His profound clinical experience in treatment and
management of complex aortic disease and his scientific work have helped to
develop surgical techniques which greatly improve outcomes of complex aortic
surgery.
Dr. Lawrence graduated from Dartmouth College and was awarded his M.D. degree
with honors from Harvard Medical School. His surgical residency and vascular
fellowship were done at Columbia-Presbyterian Medical Center in New York City.
In 1978, he joined the faculty at the University of Utah, where he served as chief
of Surgery at the Veterans Administration Hospital, chair of the Division of Vascular
Surgery and president of the medical staff. He moved to UC Irvine in 1998 to
become the associate dean for clinical affairs, vice president for specialty services,
and professor of surgery. In 2003, he moved to UCLA to become the chief of
vascular surgery and the director of the Gonda (Goldschmied) Vascular Center, as
well as the Bergman chair in vascular research.
n Sensing and imaging needs in modern vascular medicine
n Why the ongoing initiative to separate physicians from industry
December 5th, 2014 | 15:20–15:40
Vasilis Ntziachristos
KEYNOTE LECTURES
Professor Ntziachristos’ area of research encompasses the development of new
methods and devices for biological and medical imaging. The aim is to achieve
sustained improvements in the non-invasive investigation of physiological and
molecular processes in tissues. The result will be the development of novel,
minimally invasive and highly efficient methods for diagnosing and treating lifethreatening diseases such as cancer and arteriosclerosis.
Professor Ntziachristos (b. 1970) initially studied electrical engineering at Aristotle
University in Thessaloniki, Greece. After graduation, he transferred to the Faculty
of Bioengineering at the University of Pennsylvania, where he obtained his MSc.
and PhD. He was assistant Professor and Director of the Laboratory for Bio-Optics
and Molecular Imaging at Harvard University and Massachusetts General Hospital,
before being appointed to the Chair of Biological Imaging at TUM in 2007.
The Chair is closely linked with the Institute for Biological and Medical Imaging at
the Helmholtz Centre in Munich, of which Professor Ntziachristos is Director.
Peter Lawrence
Los Angeles | USA
is bad for patient care and society
December 6th, 2014 | 12:40–13:00
Frank J. Veith graduated from Cornell University Medical School before completing
an internship at Columbia-Presbyterian Hospital in New York and residency training
at Peter Bent Brigham Hospital and Harvard Medical School. In the 1970s and 80s
he turned his attention toward vascular surgery with an emphasis on lower extremity revascularization procedures and the endovascular graft repair of abdominal
aortic aneurysms. Frank Veith’s group was the first to perform an endovascular
aneurysm repair in the United States. Frank Veith held positions as Chief of Vascular
Surgery and Chairman of Surgery at Montefiore Medical Center and Albert Einstein
College of Medicine for many years. Moreover, he has held the William J. von Liebig
Chair in Vascular Surgery and has been the Vice Chairman of the Department of
Surgery. In 1995 he was elected President of the Society for Vascular Surgery, and
is past Chairman of the American Board of Vascular Surgery. He is chief-editor of
VASCULAR and is organizing the VEITH Symposium in New York for 40 years.
Frank J. Veith
New York | USA
33
FACULTY
CHAIRMAN
Technische Universität München, TUM | Munich | Germany
n Hans-Henning Eckstein
CO-CHAIRMEN
Technische Universität München, TUM | Munich | Germany
n Rüdiger Lange
n Markus Schwaiger
n Holger Poppert
n Wolfang Wall
n Michael Gee
n Alma Zernecke, Würzburg, Germany
LOCAL COORDINATING COMMITTEE
Technische Universität München, TUM | Munich | Germany
n Kathrin Berkenkamp
n Ulf Herold
n Eva Knipfer
n Jaroslav Pelisek
n Christian Reeps
n Heidi Söllner
n Bernhard Voss
n Heiko Wendorff
n Alexander Zimmermann
35
FACULTY
SCIENTIFIC FACULTY
n Anne Abbott, Melbourne, Australia
n Afshin Assadian, Vienna, Austria
n Ferdinando Auricchio, Pavia, Italy
n Eva Bartels, Munich, Germany
n Jonas Biehler, Garching, Germany
n Martin Björck, Uppsala, Sweden
n Leo Bonati, Basel, Switzerland
n Marc Bosiers, Dendermonde, Belgium
n Jan Brunkwall, Cologne, Germany
n Alison Halliday, Oxford, United Kingdom
n John Hardman, Bath / Bristol, United Kingdom
n
Haulon,
Lille, France
n Stephan
Hans-Henning
Eckstein
n Bernhard Hemmer, Munich, Germany
n Rob Hinchliffe, London, United Kingdom
n Armin Huber, Munich, Germany
n Fabien
RüdigerHyafil,
LangeMunich, Germany
n
Jacobs, Maastricht / Aachen, The Netherlands / Germany
n Michael
Markus Schwaiger
n
n
n
n
Stavros
Kakkos, Patras, Greece
Holger Poppert
Piotr
Alma Kasprzak,
Zernecke Regensburg, Germany
n Rachel Clough, London, United Kingdom
n
n
n
n
n
n Gioachino Coppi, Modena, Italy
n Thomas Köppel, Munich, Germany
n Richard Bulbulia, Oxford, United Kingdom
n Andrew Choong, London / Queensland, United Kingdom / Australia
n Tina Cohnert, Graz, Austria
n Martin Czerny, Zurich, Switzerland
n Jean Paul de Vries, Nieuwegein, The Netherlands
n Menno de Winther, Amsterdam, The Netherlands
n E. Sebastian Debus, Hamburg, Germany
n Wojciech Derwich, Frankfurt, Germany
n Florian Dick, Berne, Switzerland
n Christoph Domenig, Vienna, Austria
n Konstantinos Donas, Münster, Germany
n Arnd Dörfler, Erlangen, Germany
Richard Kellersmann, Würzburg, Germany
Wolfang Wall
Ali Khoynezhad, Los Angeles, USA
Michael Gee
Markus Kleemann, Lübeck, Germany
n Tilo Kölbel, Hamburg, Germany
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Andreas
Kühnl, Munich, Germany
Ulf Herold
Peter
Lawrence, Los Angeles, USA
Eva Knipfer
Christos
Liapis, Athens, Greece
Jaroslav Pelisek
Dieter Liepsch, Munich, Germany
Christian Reeps
Ian Loftus, London, United Kingdom
Heidi Söllner
Xavier Loyer, Paris, France
Bernhard Voss
Vladimir Makaloski, Berne, Switzerland
Alexander Zimmermann
Martin Malina, Malmö, Sweden
n Armando Mansilha, Porto, Portugal
n T. Christian Gasser, Stockholm, Sweden
n
n
n
n
n
n
n
n Richard Gibbs, London, United Kingdom
n Ross Naylor, Leicester, United Kingdom
n Bernhard Dorweiler, Mainz, Germany
n Wolf-Hans Eilenberg, Vienna, Austria
n José Fernandes e Fernandes, Lisbon, Portugal
n Bernd Gehringhoff, Münster, Germany
36
FACULTY
Tara Mastracci, Cleveland / London, USA / United Kingdom
Afshin Assadian
Bijan Modarai, London, United Kingdom
Heinrich Audebert
Frans L. Moll, Utrecht, The Netherlands
Martin Austermann
Nilo Mosquera, Ourense, Spain
n Firas Mussa, New York, USA
37
FACULTY
SPONSORS
n Vasilis Ntziachristos, Munich, Germany
GOLD
n Alexander Oberhuber, Düsseldorf, Germany
n Stefan Ockert, Luzern, Switzerland
n Klaus Overbeck, Sunderland, United Kingdom
n Giuseppe Panuccio, Münster, Germany
n Timothy A. Resch, Malmö, Sweden
n Benedikt Reutersberg, Munich, Germany
n E. Bernd Ringelstein, Münster, Germany
n Peter Ringleb, Heidelberg, Germany
n James Rudd, Cambridge, United Kingdom
SILVER
n Tobias Saam, Munich, Germany
n Hazim J. Safi, Houston, USA
n Mojtaba Sadeghi, Erding, Germany
n Dirk Sander, Tutzing, Germany
n Jürg Schmidli, Berne, Switzerland
n Julian Scott, Leeds, United Kingdom
BRONZE
n Henrik Sillesen, Copenhagen, Denmark
n Daniel Staub, Basel, Switzerland
n Markus Steinbauer, Regensburg, Germany
n Andrea Stella, Bologna, Italy
n Konrad Stock, Munich, Germany
n Jörg Tessarek, Lingen, Germany
n Giovanni Torsello, Münster, Germany
n Pavlos Tsantilas, Munich, Germany
n Frans van de Vosse, Eindhoven, The Netherlands
n Frank J. Veith, New York, USA
n Christian Weber, Munich, Germany
n Robert Whirley, Santa Rosa, USA
n Qingbo Xu, London, United Kingdom
38
EXHIBITORS
PASSIV
n
n
n
n
n
n
n Medistim Deutschland GmbH
n
n
n
n
n
APTUS Endosystems, Inc.
Boston Scientific Medizintechnik GmbH
C.R. Bard GmbH
Covidien Deutschland GmbH
GE Healthcare GmbH
Johnson & Johnson Medical GmbH
(Cordis, Ethicon, Ethicon Surgery)
Jotec GmbH
LeMaitre Vascular GmbH
MAQUET Vertrieb & Service Deutschland GmbH
Nicolai GmbH
Pharmore GmbH
Listing as per November 7th, 2014
39
DIRECTIONS
We highly recommend to use public transportation as the Klinikum rechts der Isar offers
very limited parking possibilities.
n FROM MUNICH AIRPORT
Please follow the signs “S-Bahn“ at the main terminal of the airport to the train station.
We recommend using the line S8 towards Munich (München) to the station “Ostbahnhof”.
Then change to the underground line U5 or U4 (U-Bahn) in direction to “Max-Weber-Platz”
and get off at the station “Max-Weber-Platz”. Follow the signs “Einsteinstrasse” and
“Einsteinstrasse/Klinikum rechts der Isar”.
n FROM CENTRAL TRAIN STATION (HAUPTBAHNHOF)
Follow the signs to the underground station and take line U4 /Arabellapark or U5/
Neuperlach. Get off the train at “Max-Weber-Platz” which is only four stations from the
central train station. Follow the signs “Einsteinstrasse” and “Einsteinstrasse/ Klinikum
rechts der Isar”.